Stran & Company, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Income (Loss) Per Share

Income (Loss) Per Share

9 Months Ended

Sep. 30, 2025

INCOME (LOSS) PER SHARE:

The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods in which a net loss is presented because their effect would have been anti-dilutive.

The following tables set forth the computation of basic and diluted net income per share of common stock for the three and nine months ended September 30, 2025:

	For the Three and Nine Months Ended September 30, 2025		For the Three and Nine Months Ended September 30, 2024
Warrants		10,074,195		10,074,195
Stock options		1,410,499		955,334
		11,484,694		11,029,529

For the three and nine months ended September 30, 2025 and 2024, as a result of the net losses in each of these periods, all warrants and stock options have been excluded from the calculation of diluted net loss per share and, therefore, there was no difference in the weighted average number of common shares for basic and diluted loss per share as the effect of all potentially dilutive shares outstanding was anti-dilutive.